ESH Video

ESH International Conference AN UPDATE ON HEMATOLOGICAL MALIGNANCIES, from bench to bedside

ESH International Conference AN UPDATE ON HEMATOLOGICAL MALIGNANCIES, from bench to bedside
October 28 - October 30, 2010 - Hammamet, Tunisia
Chairs :


The purpose of this conference will be to provide an update on « gold standards » in the diagnostic procedures, evaluation of prognosis and treatment of all types of hematological malignancies. Therefore, procedures having shown their “robustness” and treatments having clearly demonstrated a benefit in outcome, rather than research procedures or treatments, will be emphasized. This symposium should be of particular interest to specialists treating haematological malignancies, including younger physicians. It may also suit haematologists from less economically developed countries who want to introduce only widely validated procedures and treatments.


Thursday, October 28, 2010

I. Diagnostic and prognostic tools in haematological malignancies in 2010
08h30 - 09h00 Cytogenetic analysis S. Raynaud (Nice)
09h00 - 09h30 Flow cytometry M.C. Béné (Nancy)
09h30 - 10h00 Molecular biology: mutations, expression profiles, snp arrays S. Raynaud (Nice)
10h00 - 10h30 Imaging techniques C. Haioun (Créteil)
10h30 - 11h00 Coffee Break
II. Multiple myeloma and related disorders
11h00 - 11h45 Prognostic factors and treatment of myeloma T. Facon (Lille)
11h45 - 12h15 Macroglobulinemia, amyloidosis V. Leblond (Paris)
12h15 - 12h45 Discussion and case reports
12h45 - 14h20 Lunch
III. Lymphomas (Part I)
14h20 - 15h00 Prognostic factors and treatment of adult aggressive lymphomas G. Salles (Lyon)
15h00 - 15h30 Management of Hodgkin’s disease C. Ferme (Villejuif)
15h30 - 16h00 Non hodgkin’s lymphoma in children C. Patte (Villejuif)
16h00 - 16h30 - Discussion and case reports

16h30 - 17h00

Coffee Break
IV. Chronic lymphoid leukaemia and related disorders
17h00 - 17h30 Prognosis and treatment of CLL E. Monserrat (Barcelona)
17h30 - 18h00 Discussion and case reports

Friday, October 29, 2010

V. Acute myeloid leukaemia
09h00 - 09h20 Role of  biology in the management of acute leukemias C. Preudhomme (Lille)
09h20 - 09h50 Treatment of AML H. Dombret (Paris)
09h50 - 10h20 APL and its treatment P. Fenaux (Bobigny)
10h20 - 10h50 Discussion and case reports

10h50 - 11h20

Coffee Break
VI. Acute lymphoblastic leukaemia
11h20 - 11h50 Treatment of ALL in children A. Baruchel (Paris)
11h50 - 12h20 Treatment of adult ALL H. Dombret (Paris)
12h20 - 12h50 Discussion and case reports
12h50 - 14h20 Lunch
VII. Myelodysplastic syndromes and related disorders
14h20 - 14h50 Management of MDS P. Fenaux (Bobigny)
14h50 - 15h20 Discussion and case reports
VIII. Chronic myeloid leukaemia
15h20 - 15h50 Treatment of CML J. Goldman (London)
15h50 - 16h10 Role of biology in the management of CML C. Preudhomme (Lille)
IX. Lymphomas (Part II)
16h10 - 16h55 Prognostic factors and treatment of adult aggressive lymphomas A. Bosly (Yvoir)
16h55 - 17h25 Discussion and case reports

Saturday, October 30, 2010

X. Myeloproliferative disorders (other than CML)
08h30 - 09h00 Management of PV and ET J.J. Kiladjian (Bobigny)
09h00 - 09h20 Idiopathic myelofibrosis F. Cervantes (Barcelona)
09h20 - 09h50 Discussion and case reports

09h50 - 10h20

Coffee Break
XI. Allogeneic stem cell transplantation
10h20 - 10h50 Histocompatibility in allo SCT: familial and non familial donors N. Milpied (Nantes)
10h50 - 11h20 Allogeneic SCT in myeloid malignancies N. Milpied (Nantes)
11h20 - 11h40 Allogeneic SCT in lymphoid malignancies G. Salles (Lyon)
11h40 - 12h10 Complications of allo SCT E. Gluckman (Paris)
12h10 - 12h30 Cord blood transplantation E. Gluckman (Paris)
12h30 - 13h00 Discussion and case reports
13h00 - 14h30 Lunch
XII. Supportive care in haematological malignancies
14h30 - 15h10 Management of infection in neutropenic patients J. Klatskersky (Bruxelles)
15h10 - 15h40 Transfusion therapy Ph. Bierling (Créteil)
15h40 - 16h10 Hematopoietic growth factors B. Meddeb (Tunis)
16h40 End of the meeting

Abstract submission




Hotel Le Royal Hammamet
POB 237
8050 Yasmine Hammamet

Corporate partners